98 related articles for article (PubMed ID: 32120283)
61. Angiosarcoma.
Young RJ; Brown NJ; Reed MW; Hughes D; Woll PJ
Lancet Oncol; 2010 Oct; 11(10):983-91. PubMed ID: 20537949
[TBL] [Abstract][Full Text] [Related]
62. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
Maki RG; D'Adamo DR; Keohan ML; Saulle M; Schuetze SM; Undevia SD; Livingston MB; Cooney MM; Hensley ML; Mita MM; Takimoto CH; Kraft AS; Elias AD; Brockstein B; Blachère NE; Edgar MA; Schwartz LH; Qin LX; Antonescu CR; Schwartz GK
J Clin Oncol; 2009 Jul; 27(19):3133-40. PubMed ID: 19451436
[TBL] [Abstract][Full Text] [Related]
63. Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica.
STEWART FW; TREVES N
Cancer; 1948 May; 1(1):64-81. PubMed ID: 18867440
[No Abstract] [Full Text] [Related]
64. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
[TBL] [Abstract][Full Text] [Related]
65. Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital.
Bjerkehagen B; Smeland S; Walberg L; Skjeldal S; Hall KS; Nesland JM; Småstuen MC; Fosså SD; Saeter G
Acta Oncol; 2008; 47(8):1475-82. PubMed ID: 18607853
[TBL] [Abstract][Full Text] [Related]
66. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.
DeMartelaere SL; Roberts D; Burgess MA; Morrison WH; Pisters PW; Sturgis EM; Ho V; Esmaeli B
Head Neck; 2008 May; 30(5):639-46. PubMed ID: 18213722
[TBL] [Abstract][Full Text] [Related]
67. Angiosarcoma after conservation treatment for breast carcinoma: our experience and a review of the literature.
Fodor J; Orosz Z; Szabó E; Sulyok Z; Polgár C; Zaka Z; Major T
J Am Acad Dermatol; 2006 Mar; 54(3):499-504. PubMed ID: 16488303
[TBL] [Abstract][Full Text] [Related]
68. Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin.
Mathew P; Vakar-Lopez F; Troncoso P
Lancet Oncol; 2006 Jan; 7(1):92-3. PubMed ID: 16389189
[No Abstract] [Full Text] [Related]
69. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma.
Skubitz KM; Haddad PA
Cancer; 2005 Jul; 104(2):361-6. PubMed ID: 15948172
[TBL] [Abstract][Full Text] [Related]
70. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
Sledge GW; Neuberg D; Bernardo P; Ingle JN; Martino S; Rowinsky EK; Wood WC
J Clin Oncol; 2003 Feb; 21(4):588-92. PubMed ID: 12586793
[TBL] [Abstract][Full Text] [Related]
71. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.
Ribeiro RC; Sandrini F; Figueiredo B; Zambetti GP; Michalkiewicz E; Lafferty AR; DeLacerda L; Rabin M; Cadwell C; Sampaio G; Cat I; Stratakis CA; Sandrini R
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9330-5. PubMed ID: 11481490
[TBL] [Abstract][Full Text] [Related]
72. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.
Edmonson JH; Ryan LM; Blum RH; Brooks JS; Shiraki M; Frytak S; Parkinson DR
J Clin Oncol; 1993 Jul; 11(7):1269-75. PubMed ID: 8315424
[TBL] [Abstract][Full Text] [Related]
73. Paclitaxel (taxol).
Rowinsky EK; Donehower RC
N Engl J Med; 1995 Apr; 332(15):1004-14. PubMed ID: 7885406
[No Abstract] [Full Text] [Related]
74. Doxorubicin, paclitaxel, and cisplatin based chemotherapy for the treatment of angiosarcoma: Two case reports.
Lewcun JA; Pameijer C; Kass R; Cream L; Hershock D; Brooks AJ; Dodge DG
Int J Surg Case Rep; 2020; 68():83-87. PubMed ID: 32120283
[TBL] [Abstract][Full Text] [Related]
75. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
76. Neoadjuvant Systemic Treatment of Primary Angiosarcoma.
Heinhuis KM; IJzerman NS; van der Graaf WTA; Kerst JM; Schrage Y; Beijnen JH; Steeghs N; van Houdt WJ
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806524
[TBL] [Abstract][Full Text] [Related]
77. A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
[TBL] [Abstract][Full Text] [Related]
78. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
79. [Breast angiosarcoma induced by radiotherapy - surgical treatment options and review of literature].
Kubala O; Prokop J; Petráš L; Ihnát P; Jelínek P; Ostruszka P
Rozhl Chir; 2017; 96(8):353-358. PubMed ID: 29058926
[TBL] [Abstract][Full Text] [Related]
80. Radiation-associated angiosarcoma: diagnostic and therapeutic implications--two case reports and a review of the literature.
Cafiero F; Gipponi M; Peressini A; Queirolo P; Bertoglio S; Comandini D; Percivale P; Sertoli MR; Badellino F
Cancer; 1996 Jun; 77(12):2496-502. PubMed ID: 8640698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
